On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center designation by the National Cancer  Institute (NCI), the largest funder of cancer research in the world.  Centers who achieve this level of recognition must meet the most rigorous standards for innovative research and leading-edge clinical trials.

By earning designation as a Comprehensive Cancer Center, UVA moved into an elite group of 52 of the most outstanding cancer programs in the nation and is the only Comprehensive Cancer Center in Virginia.

UVA Cancer Center has grown tremendously over the past several years. Since 2014, their patient-care volume has grown by more than 50%, with many patients traveling great distances to access its specialists. Over the last four years, funding for cancer research at UVA has increased 45%, totaling more than $30 million in 2020.